Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Cancer Core Europe: what has been achieved one year on?

Prof Alexander Eggermont and Prof Julio Celis
Cancer Core Europe: what has been achieved one year on? ( Prof Alexander Eggermont and Prof Julio Celis )
2 Dec 2015

Cancer Core Europe: one year on (full version)

Prof Alexander Eggermont - Gustave Roussy, Villejuf, France
Cancer Core Europe: one year on (full version) ( Prof Alexander Eggermont - Gustave Roussy, Villejuf, France )
2 Dec 2015

Large B-cell non-Hodgkin’s lymphoma: Optimising therapy for elderly patients

Prof Pierre-Louis Soubeyran - Institut Bergonié, Regional Cancer Center, Bordeaux, France
Large B-cell non-Hodgkin’s lymphoma: Optimising therapy for elderly patients ( Prof Pierre-Louis Soubeyran - Institut Bergonié, Regional Cancer Center, Bordeaux, France )
18 Nov 2015

Geonomic testing may help predict metastatic risk after prostatectomy and salvage radiotherapy

Dr Robert Den - Thomas Jefferson University, Philadelphia, USA
Geonomic testing may help predict metastatic risk after prostatectomy and salvage radiotherapy ( Dr Robert Den - Thomas Jefferson University, Philadelphia, USA )
27 Oct 2015

Longer duration of ADT after radiotherapy improves disease-free survival in prostate cancer

Dr Colleen Lawton - Medical College of Wisconsin, Milwaukee, USA
Longer duration of ADT after radiotherapy improves disease-free survival in prostate cancer ( Dr Colleen Lawton - Medical College of Wisconsin, Milwaukee, USA )
27 Oct 2015

ECC 2015 scientific highlights

Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden
ECC 2015 scientific highlights ( Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden )
30 Sep 2015

ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: Systemic review

Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK
ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: Systemic review ( Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK )
28 Sep 2015

Everolimus for non-functional neuroendocrine tumours

Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA
Everolimus for non-functional neuroendocrine tumours ( Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA )
26 Sep 2015

TAT 2016: Targeted anticancer therapies

Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA
TAT 2016: Targeted anticancer therapies ( Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA )
19 Jun 2015

Round-up of the latest research on lung cancer

Dr James Spicer - Guy's Hospital, London, UK
Round-up of the latest research on lung cancer ( Dr James Spicer - Guy's Hospital, London, UK )
9 Jun 2015

Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer

Dr Simon Chowdhury - Guy's Hospital, London, UK
Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer ( Dr Simon Chowdhury - Guy's Hospital, London, UK )
9 Jun 2015

Letrozole vs observation for HR positive breast cancer

Dr Nicholas Zdenkowski - University of Newcastle, Newcastle, Australia
Letrozole vs observation for HR positive breast cancer ( Dr Nicholas Zdenkowski - University of Newcastle, Newcastle, Australia )
31 May 2015